Artzi Lab | From Bench to Bedside
ARPA-H has announced the 2024 recipients of the Open BAA awards, including the DAIRS (Disease-Agnostic Immune therapies using RNA Structure) project led by Dr. Natalie Artzi. (Link to article)
Congratulations to Dr. Natalie Artzi for being promoted to Core Faculty at the Wyss Institute for Biologically Inspired Engineering at Harvard University (Link to article)
Thank you to Politico for featuring our exciting new therapies being developed for Harvard University's first ever awarded Advanced Research Projects Agency for Health (ARPA-H) (Link to article)
We are motivated to explore how
to enhance drug delivery and efficacy
through nanoparticles and macroscale
materials (Link to article)
Excited about our research for a new treatment that could reverse hair loss caused by an autoimmune skin disease (Link to article 1) (Link to article 2) (Link to article 3) (Link to article 4)
The Artzi Lab is advancing care using advanced delivery materials (Link to article)
Our team has developed a sprayable gel to make minimally invasive surgeries simpler and safer (Link to article 1) (Link to article 2) (Link to article 3)
Thrilled to see our work featured in AIChE-CEP Magazine highlighting our development of a non-invasive tool, based on microneedles and Simoa, to monitor melanoma patients' response to immunotherapy (Link to article) (PDF)
Natalie Artzi awarded as the 2024 Acta Biomaterialia Silver Medal recipient
It was a pleasure to join the 2023 Wyss Institute Retreat, during which Natalie Artzi Chaired a panel on cancer and Michelle Dion presented her work with the greater Wyss community.
Thank you to the Langer Lab for hosting a wonderful seminar. Natalie Artzi presented on using engineering nanoparticles and microneedles to precisely modulate the immune system.
Celebrating the Nanomedicine and Drug Delivery Symposiom (NanoDDS) 2023 with all who participated. It was a joyful success thanks to Chair, Natalie Artzi, and Co-Chairs, Jinjun Shi, Tatiana Novobrantseva, Laura Sepp-Lorenzino, and Ana Jaklenec.
Congratulations to Natalie Artzi for being elected as a fellow of the Controlled Release Society
Congratulations to Maria Poley for being awarded the NIH T32 Fellowship
Watch Natalie Artzi's
2023 World Innovation Medical Forum talk here:
Michelle Dion was awarded the prestigious
IMES 2023-2024 Martin Prince Fellowship,
for her pioneering innovations in brain cancer research
Nuria Puigmal-Dominguez was awarded the Harvard Business School Blavatnik fellowship, aiming to translate our technology for the treatment of autoimmune diseases to the clinic
National Science Foundation Graduate Research Fellowship Program 2020 Michelle Dion awarded with the 2020 NSF-GRFP
Natalie Artzi wins the Bright Futures Award 2019
​
Women enabling science to reach the people who need it.
​
Brigham Clinical & Clinical News 2019
The Brigham’s Bioengineers: Forecasting Disease.
​
Stepping Strong Innovator Award 2018
The Stepping Strong Center for Trauma Innovation awarded Prof. Natalie Artzi
with funding for her research in healing infected bones using antibiotics and
localized gene therapy.
​
Controlled Release society 2018 Award
2018 Young investigator award​ Gene Delivery and Gene Editing Focus Group.
​
Brigham Health News "Tomorrow’s Medicine Today"
Summer 2018: The future will see you now. Technologies are changing the
where, what, and how of healthcare.
MicroRNA scaffold cancer therapy image as one of the award winners.
​
Prof. Natalie Artzi awarded with the Nano-Micro Letters Researcher Award.
​
​
Local scientists bolstering Joe Biden’s cancer campaign.
​
​
A Sticky Solution
​
Gene therapy technique may help prevent cancer metastasis.
​
HIGHLIGHT on Science Translational Medicine
Triple threat to colorectal cancer.
​
​
The Naked Scientists: Science News Cambridge University
Patch beats off colorectal tumours.
​
​
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results
​
National Cancer Institute Image award 2016
Cancer close up image award.
​
News Medical
Delivering microRNAs in cancer treatment: an interview with Dr Conde and Dr Artzi.
​
HIGHLIGHT on Science Translational Medicine
Efficacy by design.
​
​
Shrinking Tumors with an RNA Triple-Helix Hydrogel Glue.
​
A new way to deliver microRNAs for cancer treatment
Scientists exploit gene therapy to shrink tumors in mice with an aggressive form of
breast cancer.
​
Inside Front Cover featured in Advanced Healthcare Materials for the research paper "Tuning of
Collagen Scaffold Properties Modulates Embedded Endothelial Cell Regulatory Phenotype in
Repair of Vascular Injuries In Vivo"
​
Qmed News: 10 Biomaterial Breakthroughs You Need to Know
Specially Tailored Tissue Adhesives
​
​
Front Cover featured in Advanced Functional Materials for the research paper "Dual targeted
immunotherapy via in vivo delivery of biohybrid RNAi-peptide nanoparticles to
tumour-associated macrophages and cancer cells".
Front Cover featured in Advanced Healthcare Materials for the review "Personalizing
biomaterials for precision nanomedicine in light of local tissue microenvironment"
​
NATURE REVIEWS DRUG DISCOVERY | RESEARCH HIGHLIGHT
CANCER
Multifunctional nanodevice reverses drug resistance.
Sneaky 'nanobeacon' delivers smackdown to cancer cells' defenses
By silencing a mechanism that allows cancer cells to reject anti-cancer drugs, a new
breakthrough out of MIT and Harvard could dramatically increase the efficacy of treatment.
​
A gold Trojan nano-horse that fights cancer
Gold nanoparticles designed to kill cancer cells are showing promise.
NEW NANODEVICE DEFEATS DRUG RESISTANCE
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
​
​
New nanodevice defeats drug resistance
Tiny particles embedded in gel can turn off drug-resistance genes, then release cancer drugs.
Researchers design tailored tissue adhesives.
FOCUS on Science Translational Medicine by Buddy D. Ratner
Healing with medical implants: The body battles back.
Front Cover featured in Science Translational Medicine for the research paper "Regulation of
dendrimer:dextran material performance by the altered tissue microenvironment in
inflammation and neoplasia".
​
MIT researchers design tailored tissue adhesives
Glue can be modified for optimal performance in different types of diseased tissue.
NATURE MEDICINE | RESEARCH HIGHLIGHT
Sealants get specific.
​
MIT team aims to tailor surgical glues for specific applications
Researchers look to match material to tissue properties.
